Farrow Jeffrey S
See Remarks
Farrow Jeffrey S has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.
On the most recent filing, Farrow Jeffrey S is listed as See Remarks at Tarsus Pharmaceuticals, Inc. Inside the rolling window, Farrow Jeffrey S reported no open-market purchases and 4 open-market sales totaling $1.3M in TARS. The largest disclosed transaction in the window is a sale of 14,396 TARS shares on Jun 16, 2026, worth $877K.
Companies traded
Other insiders at TARS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Farrow Jeffrey S made?
Farrow Jeffrey S has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Farrow Jeffrey S trade?
Farrow Jeffrey S has filed SEC Form 4 disclosures for 1 company, including TARS.
When was Farrow Jeffrey S's most recent SEC Form 4 filing?
Farrow Jeffrey S's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.
What is Farrow Jeffrey S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Farrow Jeffrey S is listed as See Remarks.
What is Farrow Jeffrey S's total buy and sell value in the current window?
Inside the rolling retention window, Farrow Jeffrey S bought $0 and sold $1.3M based on SEC Form 4 filings.
What was Farrow Jeffrey S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,396 TARS shares on 2026-06-16, worth $877K, per SEC Form 4 filings.